0001179110-12-010635.txt : 20120621
0001179110-12-010635.hdr.sgml : 20120621
20120621113008
ACCESSION NUMBER: 0001179110-12-010635
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120620
FILED AS OF DATE: 20120621
DATE AS OF CHANGE: 20120621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHANNON TIMOTHY M
CENTRAL INDEX KEY: 0001207114
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 12918845
MAIL ADDRESS:
STREET 1: C/O CURAGEN CORP
STREET 2: 555LONG WHARF DR. 11TH FL.
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 7814330771
MAIL ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494-2725
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0305
4
2012-06-20
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001207114
SHANNON TIMOTHY M
CO/ CELLDEX THERAPEUTICS, INC.
119 FOURTH AVENUE
NEEDHAM
MA
02494
1
0
0
0
Common Stock
2012-06-20
4
A
0
2000
A
79212
D
On June 20, 2012, the Company awarded 2,000 shares of the Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan, subject to time-based forfeiture restrictions.
/s/ Avery W. Catlin, attorney in fact for Timothy M. Shannon
2012-06-21